Abstract
Enterococci are among the most common opportunistic hospital pathogens. This study used whole-genome sequencing (WGS) and bioinformatics to determine the antibiotic resistome, genetic support, clones and phylogenetic relationship of Enterococcus faecalis isolated from hospital environments in South Africa. Isolates were recovered from 11 frequently touched sites by patients and healthcare workers in different wards at 4 levels of healthcare (A, B, C and D) in Durban, South Africa. Following microbial identification and antibiotic susceptibility tests. Of the 245 E. faecalis isolates identified, 38 were subjected to WGS on the Illumina MiSeq platform. The tet(M) (31/38, 82%) and erm(C) (16/38, 42%) genes were the most common antibiotic resistome found in isolates originating from the different hospital environments which corroborated with their antibiotic resistance phenotypes. The isolates harboured mobile genetic elements consisting of plasmids (n=11) and prophages (n=14), that were mostly clone-specific. Of note, a large number insertion sequence (IS) families were found with the IS3 (55%), IS5 (42%), IS1595 (40%) and Tn3 Transposon been the most predominate. Microbial typing using WGS data revealed 15 clones with 6 major sequence types (ST) belonging to ST16 (n =7), ST40 (n = 6), ST21 (n =5), ST126 (n = 3), ST23 (n =3) and ST386 (n=3). Phylogenomic analysis showed that the major clones were mostly conserved within specific hospital environments. However, further metadata insights revealed the complex intra-clonal spread of these E. faecalis major clones between the sampling sites within each specific hospital setting. The results of these genomic analyses will offer insights into E. faecalis in the hospital environments relevant in the design of optimal infection prevention strategies in hospital settings.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
We are grateful to the Sequencing Core Facility, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa; the South African Research Chairs Initiative of the Department of Science and Technology and the National Research Foundation of South Africa (Grant number: 98342); and the College of Health young researcher grant, University of KwaZulu-Natal, for sponsoring this research.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The generated data used to support the findings of this study are included in the article.
